91 related articles for article (PubMed ID: 1646537)
21. [The changes of clinical characteristics in 100 Japanese amyotrophic lateral sclerosis patients between 1980 and 2000].
Kimura F; Shinoda K; Fujiwara S; Fujimura C; Nakajima H; Furutama D; Sugino M; Hanafusa T
Rinsho Shinkeigaku; 2003 Jul; 43(7):385-91. PubMed ID: 14582363
[TBL] [Abstract][Full Text] [Related]
22. A molecular genetic approach to amyotrophic lateral sclerosis.
Siddique T; Hu P; Hentati A; Deng G; Hung WY; McInnis MG; Warren AC; Rimmler J; Antonarakis S; Pericak-Vance MA
Int J Neurol; 1991-1992; 25-26():60-9. PubMed ID: 11980064
[TBL] [Abstract][Full Text] [Related]
23. Evidence for systemic immune system alterations in sporadic amyotrophic lateral sclerosis (sALS).
Zhang R; Gascon R; Miller RG; Gelinas DF; Mass J; Hadlock K; Jin X; Reis J; Narvaez A; McGrath MS
J Neuroimmunol; 2005 Feb; 159(1-2):215-24. PubMed ID: 15652422
[TBL] [Abstract][Full Text] [Related]
24. Immune system alterations in sporadic amyotrophic lateral sclerosis patients suggest an ongoing neuroinflammatory process.
Mantovani S; Garbelli S; Pasini A; Alimonti D; Perotti C; Melazzini M; Bendotti C; Mora G
J Neuroimmunol; 2009 May; 210(1-2):73-9. PubMed ID: 19307024
[TBL] [Abstract][Full Text] [Related]
25. [Prognostic significance of typical immune reactions in myocardial infarction].
Zemskov AM; Alekhina OD; Zemskov VM; Zemskov MA; Zoloedov VI
Ter Arkh; 2008; 80(1):32-7. PubMed ID: 18326224
[TBL] [Abstract][Full Text] [Related]
26. [Survival in amyotrophic lateral sclerosis].
Alcaz S; Jarebinski M; Pekmezović T; Marinković Z; Apostolski S
Srp Arh Celok Lek; 1997; 125(1-2):19-23. PubMed ID: 17974351
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-1beta converting enzyme/Caspase-1 (ICE/Caspase-1) and soluble APO-1/Fas/CD 95 receptor in amyotrophic lateral sclerosis patients.
Iłzecka J; Stelmasiak Z; Dobosz B
Acta Neurol Scand; 2001 Apr; 103(4):255-8. PubMed ID: 11328198
[TBL] [Abstract][Full Text] [Related]
28. [Clinico-immunological evaluation of the efficacy of treatment of patients with furunculosis].
Savitskaia LN
Vestn Dermatol Venerol; 1983 Mar; (3):4-9. PubMed ID: 6602435
[No Abstract] [Full Text] [Related]
29. Amyotrophic lateral sclerosis patient antibodies label Ca2+ channel alpha 1 subunit.
Kimura F; Smith RG; Delbono O; Nyormoi O; Schneider T; Nastainczyk W; Hofmann F; Stefani E; Appel SH
Ann Neurol; 1994 Feb; 35(2):164-71. PubMed ID: 8109897
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of humoral immune response in adaptive immunity in ALS patients during disease progression.
Saleh IA; Zesiewicz T; Xie Y; Sullivan KL; Miller AM; Kuzmin-Nichols N; Sanberg PR; Garbuzova-Davis S
J Neuroimmunol; 2009 Oct; 215(1-2):96-101. PubMed ID: 19682755
[TBL] [Abstract][Full Text] [Related]
31. [Clinico-immunological correlations in psoriatic arthritis based on data from determining cellular (T- and B-lymphocytes) and humoral (IgG, IgA and IgM) immunity factors].
Nikulin NK; Starostina ZD; Komarova VD
Vestn Dermatol Venerol; 1981 Sep; (9):10-4. PubMed ID: 6975543
[No Abstract] [Full Text] [Related]
32. [Charcot's disease and juvenile amyotrophic lateral sclerosis].
Ben Hamida M; Hentati F
Rev Neurol (Paris); 1984; 140(3):202-6. PubMed ID: 6729330
[TBL] [Abstract][Full Text] [Related]
33. [Frontal lobe dysfunction in ALS].
Alcaz S; Apostolski S
Srp Arh Celok Lek; 1995; 123(9-10):266-70. PubMed ID: 17974446
[TBL] [Abstract][Full Text] [Related]
34. [Clinico-immunological parallels in patients with iron-deficiency anemia].
Golovin AA; Red'kin IuV; Sokolova TF
Ter Arkh; 1988; 60(10):103-5. PubMed ID: 3265542
[TBL] [Abstract][Full Text] [Related]
35. [Changes in the immunological reactivity of patients with disseminated sclerosis treated by prednisolone and the preparation Proper-Myl].
Iarosh AA; Macheret EL; Iarosh AA; Zapadniuk BV
Vrach Delo; 1990 Feb; (2):83-6. PubMed ID: 2339565
[TBL] [Abstract][Full Text] [Related]
36. [Clinico-immunologic studies in rhinosinusogenic cerebral arachnoiditis].
Mukhamedzhanov NZ; Blagoveshchenskaia NS; Simonova AV
Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(2):98-100. PubMed ID: 2160181
[TBL] [Abstract][Full Text] [Related]
37. [Clinico-immunologic parallels in evaluating the treatment of multiple sclerosis].
Chernigovskaia NV; Ogurtsov RP; Matveeva TS; Popov VG; Puzyreva VP
Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(2):24-8. PubMed ID: 2160163
[TBL] [Abstract][Full Text] [Related]
38. Survival rate of patients with amyotrophic lateral sclerosis in Wakayama Prefecture, Japan, 1966 to 2005.
Kihira T; Yoshida S; Okamoto K; Kazimoto Y; Ookawa M; Hama K; Miwa H; Kondo T
J Neurol Sci; 2008 May; 268(1-2):95-101. PubMed ID: 18164728
[TBL] [Abstract][Full Text] [Related]
39. Misdiagnosis in patients with amyotrophic lateral sclerosis.
Belsh JM; Schiffman PL
Arch Intern Med; 1990 Nov; 150(11):2301-5. PubMed ID: 2241438
[TBL] [Abstract][Full Text] [Related]
40. [Various regional features of the clinical picture and epidemiology of amyotrophic lateral sclerosis].
Alaev BA
Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(9):1334-7. PubMed ID: 6227173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
